DNAJC16 (DnaJ Heat Shock Protein Family (Hsp40) Member C16) is a member of the DnaJ/Hsp40 family of co-chaperones that play essential roles in cellular protein homeostasis. The DNAJC16 protein contains the characteristic J domain that enables interaction with Hsp70 [heat shock proteins](/entities/heat-shock-proteins), facilitating protein folding, refolding of stress-damaged proteins, and targeting of misfolded proteins for degradation. This gene is expressed in various tissues, with significant expression in the brain, where it contributes to neuronal protein quality control mechanisms that are critical for maintaining cellular function and viability. [@hipp2019]
Gene Information
<div class="infobox infobox-gene"> [@balchin2016]
| Property | Value | [@kim2013] |----------|-------| [@hartl2011] | Gene Symbol | DNAJC16 | [@mayer2005] | Full Name | DnaJ Heat Shock Protein Family (Hsp40) Member C16 | [@rosenthal2011] | Chromosomal Location | 1p36.21 | [@liberek2008] | Gene ID | 55133 | | RefSeq | NM_001304477 | | Protein Length | 382 amino acids | | Molecular Weight | ~42 kDa | | Alternative Names | DNAJC16, DJC16, JPD16 |
</div>
Protein Structure and Domains
DNAJC16 contains the hallmark domains of the DnaJ protein family:
J domain: The N-terminal domain (approximately 70 amino acids) containing the highly conserved HPD (His-Pro-Asp) motif that is essential for stimulating Hsp70 ATPase activity. This domain mediates the interaction with Hsp70 chaperones.
...
DNAJC16
title: DNAJC16 Gene
DNAJC16 Gene
Overview
DNAJC16 (DnaJ Heat Shock Protein Family (Hsp40) Member C16) is a member of the DnaJ/Hsp40 family of co-chaperones that play essential roles in cellular protein homeostasis. The DNAJC16 protein contains the characteristic J domain that enables interaction with Hsp70 [heat shock proteins](/entities/heat-shock-proteins), facilitating protein folding, refolding of stress-damaged proteins, and targeting of misfolded proteins for degradation. This gene is expressed in various tissues, with significant expression in the brain, where it contributes to neuronal protein quality control mechanisms that are critical for maintaining cellular function and viability. [@hipp2019]
Gene Information
<div class="infobox infobox-gene"> [@balchin2016]
| Property | Value | [@kim2013] |----------|-------| [@hartl2011] | Gene Symbol | DNAJC16 | [@mayer2005] | Full Name | DnaJ Heat Shock Protein Family (Hsp40) Member C16 | [@rosenthal2011] | Chromosomal Location | 1p36.21 | [@liberek2008] | Gene ID | 55133 | | RefSeq | NM_001304477 | | Protein Length | 382 amino acids | | Molecular Weight | ~42 kDa | | Alternative Names | DNAJC16, DJC16, JPD16 |
</div>
Protein Structure and Domains
DNAJC16 contains the hallmark domains of the DnaJ protein family:
J domain: The N-terminal domain (approximately 70 amino acids) containing the highly conserved HPD (His-Pro-Asp) motif that is essential for stimulating Hsp70 ATPase activity. This domain mediates the interaction with Hsp70 chaperones.
Glycine/phenylalanine-rich region: A flexible linker region between the J domain and C-terminal regions that facilitates protein-protein interactions and may contain serine phosphorylation sites.
C-terminal client-binding domain: Contains regions predicted to form coiled-coil structures that recognize and bind unfolded or misfolded client proteins.
The three-dimensional structure follows the canonical DnaJ fold, with the J domain at the N-terminus connected to the substrate-binding region through a flexible linker.
Expression Pattern
DNAJC16 exhibits tissue-specific expression:
Central nervous system: High expression in brain regions including the cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum. Expression is detected in both neuronal and glial cell populations.
Peripheral tissues: Moderate expression in heart, skeletal muscle, liver, and kidney.
Cellular localization: Cytosolic localization with potential association with membrane compartments and organelles involved in protein quality control, including the endoplasmic reticulum and mitochondria.
In the brain, DNAJC16 expression is particularly notable in regions associated with neurodegenerative processes, suggesting potential involvement in disease pathogenesis.
Molecular Functions
Co-chaperone Activity
DNAJC16 functions primarily as a co-chaperone:
Hsp70 recruitment and stimulation: The J domain of DNAJC16 interacts with and stimulates the ATPase activity of Hsp70 proteins, enabling substrate protein processing.
Substrate recognition: The C-terminal domains recognize hydrophobic regions exposed in misfolded or partially unfolded proteins.
Protein folding assistance: DNAJC16 can stabilize partially folded intermediates and prevent aggregation during the folding process.
Targeted degradation: DNAJC16 can direct misfolded proteins to the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) (UPS) or [autophagy](/entities/autophagy) pathways for degradation.
Cellular Pathways
DNAJC16 participates in several cellular processes:
Cytosolic protein quality control: General management of cytosolic protein folding and clearance
ER-associated degradation (ERAD): Potential involvement in retrotranslocation of misfolded proteins from the ER
Mitochondrial protein quality control: May contribute to mitochondrial protein homeostasis
Stress response: Induction and activation under proteotoxic stress conditions
Role in Neurodegenerative Diseases
Alzheimer's Disease
In Alzheimer's disease (AD), DNAJC16 may play several roles:
[Amyloid-beta](/proteins/amyloid-beta) quality control: Potential involvement in managing amyloid-beta peptide aggregation and clearance through co-chaperone activity.
[Tau protein](/proteins/tau) homeostasis: May assist in tau protein folding and clearance, as tau pathology involves misfolded protein accumulation.
Neuronal proteostasis: The general protein quality control functions of DNAJC16 could help maintain neuronal health, which declines with age and AD progression.
Synaptic protein maintenance: Given the importance of synaptic protein turnover in AD, DNAJC16 may help maintain synaptic protein homeostasis.
Parkinson's Disease
DNAJC16 involvement in Parkinson's disease includes:
[Alpha-synuclein](/proteins/alpha-synuclein) processing: The aggregation of alpha-synuclein is central to PD pathogenesis; DNAJC16 may help prevent alpha-synuclein aggregation through Hsp70-mediated quality control.
[LRRK2](/entities/lrrk2) protein quality control: DNAJC16 may interact with proteins involved in PD pathogenesis, including LRRK2.
Dopaminergic neuron vulnerability: The specific vulnerability of dopaminergic [neurons](/entities/neurons) in PD may involve protein quality control deficits that DNAJC16 could help address.
Mitochondrial function: PD involves mitochondrial dysfunction; DNAJC16 may contribute to mitochondrial protein quality control.
Amyotrophic Lateral Sclerosis
In ALS:
Protein aggregate management: Many ALS-associated proteins form aggregates; DNAJC16 may participate in managing [TDP-43](/mechanisms/tdp-43-proteinopathy), FUS, SOD1, and [C9orf72](/entities/c9orf72) protein aggregates.
ER stress response: ALS involves ER stress; DNAJC16 may contribute to ERAD and overall ER homeostasis.
RNA granule dynamics: Some DNAJ proteins regulate RNA granule assembly/disassembly; DNAJC16 may influence stress granule and P-body dynamics relevant to ALS.
Frontotemporal dementia: Protein quality control in FTD pathogenesis
Prion diseases: Prion protein misfolding and clearance pathways
Therapeutic Potential
DNAJC16 represents a promising therapeutic target:
Chaperone enhancement: Small molecules that enhance DNAJC16 function or its interaction with Hsp70 could improve protein clearance in neurodegeneration.
Expression modulation: Strategies to increase DNAJC16 expression could bolster cellular protein quality control capacity.
Targeted protein degradation: Understanding DNAJC16's client proteins could enable targeted degradation approaches.
Combination therapy: Modulating multiple components of the protein quality control network may provide synergistic benefits.
Research Methods
Investigating DNAJC16 involves:
Gene expression studies: qRT-PCR, RNA-seq to measure mRNA levels
Protein analysis: Western blotting, immunoprecipitation
Functional assays: Protein refolding assays, aggregate clearance assays
Model systems: Cell culture, neuronal differentiation models
Summary
DNAJC16 is a DnaJ/Hsp40 family co-chaperone with important functions in cellular protein quality control. Through its J domain-mediated interaction with Hsp70 proteins, DNAJC16 facilitates protein folding, prevents protein aggregation, and targets misfolded proteins for degradation. Given the critical importance of protein homeostasis in neurons, which are post-mitotic and cannot dilute damaged proteins through cell division, DNAJC16 likely plays a significant role in neuronal survival and function. While specific roles in individual neurodegenerative diseases require further investigation, the fundamental importance of protein quality control in neurodegeneration makes DNAJC16 an important protein to study. Understanding DNAJC16's function and regulation may lead to therapeutic strategies for enhancing neuronal protein homeostasis in disease states.
See Also
[Hsp40 Family](/entities/hsp40-family) — DnaJ/Hsp40 co-chaperone family
[Hsp70 Family](/entities/hsp70-family) — Hsp70 molecular chaperone family
[Protein Homeostasis](/mechanisms/protein-homeostasis) — Protein quality control mechanisms
[Unfolded Protein Response](/mechanisms/endoplasmic-reticulum-stress)mechanisms/er-stress-unfolded-protein-response) — Cellular stress response
[Molecular Chaperones](/mechanisms/molecular-chaperones) — Protein folding assistants
[DNAJC Gene Family](/genes) — Other DNAJC genes in NeuroWiki
[Alzheimer's Disease](/diseases/alzheimers-disease) — Protein aggregation in AD
[Parkinson's Disease](/diseases/parkinsons-disease) — Protein homeostasis in PD
[PubMed: DNAJC16](https://pubmed.ncbi.nlm.nih.gov/?term=DNAJC16+neurodegeneration) — Literature search
References
[Kampinga HH et al., Guidelines for the nomenclature of the Hsp70 molecular chaperone family (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19765564/)
[Cox D et al., Protein homeostasis in neurodegenerative disease: A strategic opportunity for drug discovery (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32744208/)
[Klaips CL et al., Cellular pathways that protect neurons from proteostasis failure (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29415856/)
[Hipp MS et al., Proteostasis failure in neurodegenerative diseases: Towards new therapeutic strategies (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/30605869/)
[Balchin D et al., In vivo aspects of protein folding and quality control (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27230645/)
[Kim YE et al., Molecular chaperone functions in protein folding and proteostasis (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23650619/)
[Hartl FU et al., Molecular chaperones in protein folding and proteostasis (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21616445/)
[Mayer MP et al., Hsp70 chaperones: Cellular functions and molecular mechanism (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15893391/)
[Rosenthal LA et al., The DNAJ/Hsp40 family: Key regulators of protein folding and quality control (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21693579/)
[Liberek K et al., The DnaJ/DnaK chaperone system in protein quality control (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18650913/)